Comment on research report by Gruson and colleagues, this issue

被引：0

作者：

Huff, Carol Ann ^{[1
]}

Merkies, Ingemar S. J. ^{[2
,3
]}

Hughes, Richard A. C. ^{[4
]}

Cornblath, David R. ^{[5
]}

机构：

[1] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA

[2] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands

[3] Spaarne Hosp, Hoofddorp, Netherlands

[4] MRC Neuromuscular Dis Ctr, Inst Neurol, London, England

[5] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA

来源：

关键词：

ANTIBODY DEMYELINATING NEUROPATHY; PLACEBO-CONTROLLED TRIAL; RITUXIMAB;

D O I：

10.1111/j.1529-8027.2011.00349.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：157 / 158

页数：2

共 7 条

[1] Placebo-Controlled Trial of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Antibody Demyelinating Neuropathy
Dalakas, Marincis C.
Rakocevic, Goran
Salajegheh, Mohammad
Dambrosia, James M.
Hahn, Angelika F.
Raju, Raghavan
McElroy, Beverly
[J]. ANNALS OF NEUROLOGY, 2009, 65 (03) : 286 - 293
[2] Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy
Gruson, Berengere
Ghomari, Kamel
Beaumont, Marie
Garidi, Reda
Just, Alain
Merle, Philippe
Merlusca, Lavinia
Marolleau, Jean P.
Royer, Bruno
[J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 (03) : 180 - 185
[3] Léger JM, 2011, J PERIPHER NERV SYST, V16, pS73
[4] Lunn M P, 2008, Neuromuscul Disord, V18, P85, DOI 10.1016/j.nmd.2007.08.004
[5] Merkies I S J, 2006, Neuromuscul Disord, V16, P149, DOI 10.1016/j.nmd.2005.12.003
[6] MERKIES ISJ, 2001, THESIS ERASMUS U ROT
[7] Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
van Nes, S. I.
Vanhoutte, E. K.
van Doorn, P. A.
Hermans, M.
Bakkers, M.
Kuitwaard, K.
Faber, C. G.
Merkies, I. S. J.
[J]. NEUROLOGY, 2011, 76 (04) : 337 - 345